Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ADMA Biologics Inc (NASDAQ:ADMA)

5.52
Delayed Data
As of 3:59pm ET
 -0.01 / -0.18%
Today’s Change
4.15
Today|||52-Week Range
9.58
-31.60%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close5.53
Today’s open5.59
Day’s range5.44 - 5.60
Volume4,400
Average volume (3 months)50,759
Market cap$69.6M
Dividend yield--
Data as of 3:59pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+4.42%
Earnings growth (this year)+7.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+21.34%
P/E ratioNM
Price/Sales11.71
Price/Book70.47

Competitors

 Today’s
change
Today’s
% change
ONSOncobiologics Inc-0.28-8.95%
CRMDCorMedix Inc+0.05+2.81%
PIRSPieris Pharmaceutica...+0.02+1.27%
NEPTNeptune Technologies...+0.05+4.84%
Data as of 4:01pm ET, 12/06/2016

Financials

Next reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$7.2M
Annual profit (last year)-$18.0M
Net profit margin-250.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Adam S. Grossman
Chief Financial &
Principal Accounting Officer, VP
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts


Search for Jobs